Quantcast

Latest PARP inhibitor Stories

2014-11-24 23:08:39

RnRMarketResearch.com adds “Market Research Report on Global and Chinese Olaparib (CAS 763113-22-0) Industry, 2009-2019” Latest Report to its store. Dallas,

2014-10-08 12:25:30

Sales of Breast Cancer Therapies are Expected to Almost Double Through 2023, Fueled by Growth in Several Distinct Market Segments, According to Findings from Decision Resources Group BURLINGTON,

2014-09-22 08:28:11

Presentations include first Phase 2 results evaluating investigational compound Veliparib in patients with non-small cell lung cancer NORTH CHICAGO, Ill., Sept.

Gene Increases Risk Of Developing breast Cancer To One In Three By Age 70
2014-08-08 03:08:44

Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy.

2014-06-03 12:27:34

Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime.

2014-04-07 12:33:35

The Most Promising Emerging Agents in Development for Triple Negative Breast Cancer Target Only Specific Patient Subsets, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-04-04 12:23:54

Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70.

2014-02-14 12:23:35

The Jeffrey Epstein VI Foundation backs the FDA's landmark decision to approve inhibitor cocktails for melanoma. NEW YORK, Feb.


Word of the Day
quotha
  • Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.
The word 'quotha' is an alteration of 'quoth he'.
Related